Amoah Yeboah-Korang

Amoah Yeboah-Korang , MD,MPH

Assistant Professor of Clinical

Medical Sciences Building
231 Albert Sabin Way ML 0595
Cincinnati, Ohio 45267
Phone 513-558-7200
Fax 513-558-6013
Email yeboahah@ucmail.uc.edu

Education

BS, MS: University of Massachusetts Lowell, MA, 2005 (Biology)

MD, MPH: University of Connecticut School of Medicine Farmingon, CT, 2012

Residency: Rush University Medical Center Chicago, IL, 2015 (Internal Medicine)

Fellowship: NorthShore University Health System Evanston, IL, 2018 (Gastroenterology)

Fellowship: University of Michigan Health System Ann Arbor, MI, 2019 (Transplant Hepatology)

Certifications

American Board of Internal Medicine (Gastroenterology) (Certification Date: 10-17-2018 )

American Board of Internal Medicine (Certification Date: 08-11-2015 )

American Board of Internal Medicine (Transplant Medicine) (Certification Date: 10-15-2020 )

Clinical Interests

Gastroenterology

Transplant Hepatology

Acute Liver Failure

Alcoholic Liver Disease

Autoimmune Hepatitis

Fatty Liver

Specialities

Gastroenterology

Internal Medicine

Transplant Hepatology

Research Support

Grant: #2018 Research Seed Investigators:Yeboah-Korang, Amoah 07-01-2019 -06-30-2020 American Association for the Study of Liver Diseases AASLD Foundation Advanced/ Transplant Hepatology Award Role:PI $26,000.00 Awarded Level:Private Non-Profit

Publications

Peer Reviewed Publications

Yeboah-Korang, Amoah; Louissaint, Jeremy; Tsung, Irene; Prabhu, Sharmila; Fontana, Robert J (2020. ) Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.Drug safety, , 43 (4 ) ,371-377 More Information

Tsung, Irene; Dolan, Russell; Lao, Christopher D; Fecher, Leslie; Riggenbach, Kane; Yeboah-Korang, Amoah; Fontana, Robert J (2019. ) Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.Alimentary pharmacology & therapeutics, , 50 (7 ) ,800-808 More Information

Yeboah-Korang, Amoah; Gentile, Nicole M; Fimmel, Claus J (2018. ) PRO: Patients With Hepatitis C Virus With Pretreatment Metavir Stage 3 Fibrosis Do Not Require Hepatocellular Carcinoma Surveillance After Sustained Virological Response.Clinical liver disease, , 12 (5 ) ,133-136 More Information

Yeboah-Korang, Amoah; Beig, Mohammad I; Khan, Mohammad Q; Goldstein, Jay L; Macapinlac, Don M; Maurer, Darryck; Sonnenberg, Amnon; Fimmel, Claus J (2018. ) Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert.Journal of translational internal medicine, , 6 (2 ) ,82-89 More Information

Yeboah-Korang, Amoah; Kleppinger, Alison; Fortinsky, Richard H (2011. ) Racial and ethnic group variations in service use in a national sample of Medicare home health care patients with type 2 diabetes mellitus.Journal of the American Geriatrics Society, , 59 (6 ) ,1123-9 More Information

Fang, Jiayun M; Lamps, Laura; Yeboah-Korang, Amoah; Cheng, Jerome; Westerhoff, Maria (2021. ) De Novo Inflammatory Bowel Disease Rarely Occurs During Posttransplant Immunosuppression.American journal of clinical pathology, , More Information

Contact Information

Academic - Medical Sciences Building
231 Albert Sabin Way ML 0595
CincinnatiĀ  Ohio, 45267
Phone: 513-558-7200
Fax: 513-558-6013
yeboahah@ucmail.uc.edu